// App-Quantinova.ai

3192 : Long-Term Survival With Cybord Induction Therapy In Newly Diagnosed Multiple Myeloma

Researchers

Presenter

  • Craig B. Reeder

Principal Investigators

  • Donna E. Reece

  • Vishal Kukreti

  • Jose F Leis

  • Rodger Tiedemann

  • Jacy Spong

  • Angela Mayo

  • Keith Stewart

  • Joseph Mikhael

  • Christine I. Chen

  • Suzanne Trudel

  • Kristina Laumann

  • Joseph Hentz

  • Giovani Piza

  • Rafael Fonseca

  • P. Leif Bergsagel

Medical Centers

  • Cancer Center, Mayo Clinic, Rochester, MN

  • Mayo Clinic Arizona, Phoenix, AZ

  • Mayo Clinic, Scottsdale, AZ

  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Mayo Clinic, Scottsdale, AZ

  • Adult Blood and Marrow Transplant, Mayo Clinic Arizona, Phoenix, AZ

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Cancer Center, Mayo Clinic, Scottsdale, AZ

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Mayo Clinic Scottsdale, Scottsdale, AZ

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Peripheral neuropathy

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Bortezomib

  • Acyclovir

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved